203 related articles for article (PubMed ID: 27138103)
1. Deferoxamine-induced increase in the intracellular iron levels in highly aggressive breast cancer cells leads to increased cell migration by enhancing TNF-α-dependent NF-κB signaling and TGF-β signaling.
Liu P; He K; Song H; Ma Z; Yin W; Xu LX
J Inorg Biochem; 2016 Jul; 160():40-8. PubMed ID: 27138103
[TBL] [Abstract][Full Text] [Related]
2. Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism.
Chen C; Wang S; Liu P
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597263
[TBL] [Abstract][Full Text] [Related]
3. Deferoxamine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxic shock in mice.
Wang S; Liu C; Pan S; Miao Q; Xue J; Xun J; Zhang Y; Gao Y; Duan X; Fan Y
Biochem Biophys Res Commun; 2015 Sep; 465(2):305-11. PubMed ID: 26277391
[TBL] [Abstract][Full Text] [Related]
4. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of IL-8 by iron chelator in human epithelial cells is independent from NF-kappaB but involves ERK1/2- and p38 kinase-dependent activation of AP-1.
Choi EY; Park ZY; Choi EJ; Oh HM; Lee S; Choi SC; Lee KM; Im SH; Chun JS; Jun CD
J Cell Biochem; 2007 Dec; 102(6):1442-57. PubMed ID: 17471497
[TBL] [Abstract][Full Text] [Related]
6. Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells.
Boudreau HE; Casterline BW; Rada B; Korzeniowska A; Leto TL
Free Radic Biol Med; 2012 Oct; 53(7):1489-99. PubMed ID: 22728268
[TBL] [Abstract][Full Text] [Related]
7. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
[TBL] [Abstract][Full Text] [Related]
8. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress.
Sappey C; Boelaert JR; Legrand-Poels S; Forceille C; Favier A; Piette J
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1049-61. PubMed ID: 8554902
[TBL] [Abstract][Full Text] [Related]
9. TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation.
Yoshimatsu Y; Wakabayashi I; Kimuro S; Takahashi N; Takahashi K; Kobayashi M; Maishi N; Podyma-Inoue KA; Hida K; Miyazono K; Watabe T
Cancer Sci; 2020 Jul; 111(7):2385-2399. PubMed ID: 32385953
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
11. CXCL1 regulation in human pulmonary epithelial cells by tumor necrosis factor.
Shieh JM; Tsai YJ; Tsou CJ; Wu WB
Cell Physiol Biochem; 2014; 34(4):1373-84. PubMed ID: 25301363
[TBL] [Abstract][Full Text] [Related]
12. Iron chelator triggers inflammatory signals in human intestinal epithelial cells: involvement of p38 and extracellular signal-regulated kinase signaling pathways.
Choi EY; Kim EC; Oh HM; Kim S; Lee HJ; Cho EY; Yoon KH; Kim EA; Han WC; Choi SC; Hwang JY; Park C; Oh BS; Kim Y; Kimm KC; Park KI; Chung HT; Jun CD
J Immunol; 2004 Jun; 172(11):7069-77. PubMed ID: 15153529
[TBL] [Abstract][Full Text] [Related]
13. Iron chelation acutely stimulates fetal human intestinal cell production of IL-6 and VEGF while decreasing HGF: the roles of p38, ERK, and JNK MAPK signaling.
Markel TA; Crisostomo PR; Wang M; Herring CM; Lahm T; Meldrum KK; Lillemoe KD; Rescorla FJ; Meldrum DR
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G958-63. PubMed ID: 17204543
[TBL] [Abstract][Full Text] [Related]
14. Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
Shatrov VA; Boelaert JR; Chouaib S; Dröge W; Lehmann V
Eur Cytokine Netw; 1997 Mar; 8(1):37-43. PubMed ID: 9110146
[TBL] [Abstract][Full Text] [Related]
15. Iron chelator induces MIP-alpha/CCL20 in human intestinal epithelial cells: implication for triggering mucosal adaptive immunity.
Lee HJ; Choi SC; Choi EY; Lee MH; Seo GS; Kim EC; Yang BJ; Lee MS; Shin YI; Park KI; Jun CD
Exp Mol Med; 2005 Aug; 37(4):297-310. PubMed ID: 16155407
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines.
Bajbouj K; Shafarin J; Hamad M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818764470. PubMed ID: 29562821
[TBL] [Abstract][Full Text] [Related]
17. Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells.
Koo SW; Casper KA; Otto KB; Gira AK; Swerlick RA
J Invest Dermatol; 2003 May; 120(5):871-9. PubMed ID: 12713595
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of iron chelator-induced IL-8 synthesis via MAP kinase and NF-kappaB in immortalized and malignant oral keratinocytes.
Lee HJ; Lee J; Lee SK; Lee SK; Kim EC
BMC Cancer; 2007 Sep; 7():176. PubMed ID: 17850672
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of Antrodia cinnamomea sulfated polysaccharide on the suppression of lung cancer cell growth and migration via induction of transforming growth factor β receptor degradation.
Lu MK; Lin TY; Chao CH; Hu CH; Hsu HY
Int J Biol Macromol; 2017 Feb; 95():1144-1152. PubMed ID: 27818294
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
